Criteria for deciding cost-effectiveness for expensive new anti-cancer agents

J Cancer Res Ther. 2008 Jan-Mar;4(1):1-2. doi: 10.4103/0973-1482.39685.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / economics*
  • Antineoplastic Agents / therapeutic use*
  • Cost-Benefit Analysis*
  • Humans
  • Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents